DETAILS, FICTION AND RIBAVIRIN

Proteolysis-targeting chimeras (PROTACs) and molecular glue degraders (MGDs) are probably the most maturely created TPD methods. Within this overview, we target the two preclinical experiments and clinical trials to deliver an extensive summary of the protection and clinical usefulness of PROTACs and MGDs in hematologic malignancies over the past t